Needham & Company LLC reaffirmed their hold rating on shares of Cognyte Software (NASDAQ:CGNT – Free Report) in a research note published on Tuesday morning, Benzinga reports. Separately, StockNews.com cut shares of Cognyte Software from a strong-buy rating to a buy rating in a research note on Thursday, March 7th. Read Our Latest Research Report […]
Cognyte Software (NASDAQ:CGNT) Reaches New 1-Year High at $7 40 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cognyte Software (NASDAQ:CGNT) Sets New 12-Month High at $7 40 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cognyte Software (NASDAQ:CGNT – Get Free Report) announced its earnings results on Wednesday. The medical device company reported $0.34 earnings per share for the quarter, MarketWatch Earnings reports. Cognyte Software had a negative return on equity of 34.83% and a negative net margin of 24.78%. The firm had revenue of $79.40 million for the quarter, […]
Research analysts at StockNews.com started coverage on shares of Cognyte Software (NASDAQ:CGNT – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the medical device company’s stock. Separately, Evercore ISI raised their target price on Cognyte Software from $3.00 to $5.00 in a report on Friday, June 16th. […]